MK0859 Dose-Ranging Study (0859-003)
NCT00325455 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 500
Last updated 2015-03-02
Summary
To assess the cholesterol changing effects of MK0859 in patients with primary hypercholesterolemia or mixed dyslipidemia.
Conditions
- Hypercholesterolemia
- Mixed Hyperlipemia
Interventions
- DRUG
-
MK0859
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Medical Monitor · Merck Sharp & Dohme LLC
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-06-30
- Primary Completion
- 2007-02-28
- Completion
- 2007-03-31
More Related Trials
-
Lipid Efficacy Study (0524B-022)(COMPLETED)
NCT00269217 ·Status: COMPLETED ·Phase: PHASE3
-
MK-0524B Lipid Study (MK-0524B-063)
NCT00479882 ·Status: COMPLETED ·Phase: PHASE3
-
Investigational Drug Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-801)
NCT00092599 ·Status: COMPLETED ·Phase: PHASE3
-
MK0354 Clinical Efficacy and Tolerability Study (0354-004)
NCT00337415 ·Status: TERMINATED ·Phase: PHASE2
-
Lipid Efficacy and Safety in Participants With Mixed Hyperlipidemia (MK-0524B-024)
NCT00289900 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Safety and Efficacy of Anacetrapib (MK-0859) When Added to Ongoing Statin Therapy in Japanese Participants With Heterozygous Familial Hypercholesterolemia (MK-0859-050)
NCT01824238 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Assess the Tolerability and Efficacy of Anacetrapib (MK-0859) Co-Administered With Statin in Participants With Heterozygous Familial Hypercholesterolemia (MK-0859-020)
NCT01524289 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Safety and Efficacy of Anacetrapib (MK-0859) When Added to Ongoing Statin Therapy in Japanese Participants With Dyslipidemia (MK-0859-051 AM1)
NCT01760460 ·Status: COMPLETED ·Phase: PHASE3
-
Safety, Pharmacokinetics and Pharmacodynamics of LGT209 in Healthy Volunteers With Elevated Cholesterol and in Hypercholesterolemic Patients Treated With Statins
NCT01859455 ·Status: COMPLETED ·Phase: PHASE1
-
To Assess the Safety, Efficacy and Tolerability of CKD-519, Administered With HMG-CoA Reductase Inhibitors
NCT02977065 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Trial to Assess the Long Term Safety and Tolerability of MK-0653C in Japanese Participants With Hypercholesterolemia (MK-0653C-384)
NCT02460159 ·Status: COMPLETED ·Phase: PHASE3
-
A Long-term Safety and Tolerability Study of Ezetimibe Plus Atorvastatin in Participants With Coronary Heart Disease, Multiple Risk Factors, or Hypercholesterolemia Not Controlled by Atorvastatin (P01418/MK-0653-032)
NCT03882996 ·Status: COMPLETED ·Phase: PHASE3
-
A Multicenter Study to Evaluate the Cholesterol Lowering Effects of Two Marketed Products in Patients With Type 2 Diabetes Mellitus and Hypercholesterolemia (MK-0653A-077)
NCT00110435 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) in Adults With Heterozygous Familial Hypercholesterolemia (MK-0616-017/CORALreef HeFH)
NCT05952869 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Safety and Efficacy of Anacetrapib (MK-0859) When Added to Ongoing Statin Therapy (MK-0859-021)
NCT01717300 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TA-8995 After Multiple Doses in Healthy Subjects
NCT01879020 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Extended Release (ER) Niacin/Laropiprant When Added to Ongoing Lipid-Modifying Therapy in Patients With High Cholesterol or Abnormal Lipid Levels (MK-0524A-133)
NCT01274559 ·Status: TERMINATED ·Phase: PHASE3
-
A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Administering Multiple Oral Doses of GSK1292263 Alone and With Atorvastatin
NCT01218204 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess the Efficacy, Safety and Tolerability of Different Doses of AZD0780 in Patients With Dyslipidemia
NCT06173570 ·Status: COMPLETED ·Phase: PHASE2
-
Lipid Biomarker Study in Men With Dyslipidemia After Simvastatin Treatment (Study MK-0000-140)(COMPLETED)
NCT00935259 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Trial to Evaluate the Efficacy of a Dyslipidemic Therapy in Mexican Population
NCT03696940 ·Status: UNKNOWN ·Phase: PHASE3
-
A Multiple Ascending Dose Study of ETC-1002 in Subjects With Mild Dyslipidemia
NCT01105598 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Efficacy and Safety of Omacor, Co-Administered With Atorvastatin, in Subjects With Hypertriglyceridemia
NCT00435045 ·Status: COMPLETED ·Phase: PHASE3
-
An Investigational Drug Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-804)(COMPLETED)
NCT00092638 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Trial to Evaluate the Efficacy and Safety of DW1125 and DW1125A
NCT05970679 ·Status: COMPLETED ·Phase: PHASE3